← Eichor
Study identifier: NCT06128915 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses

Condition: Aging  ·  Sponsor: State University of New York at Buffalo

PhasePhase 4
Planned participants60
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersYes

About this study

This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.

This description comes directly from the study's public registry record.

Talk to the study team

Elsa Bou Ghanem, PhD  ·  7168292422  ·  elsaboug@buffalo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University at BuffaloBuffalo, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06128915